Pages that link to "Q51669881"
Jump to navigation
Jump to search
The following pages link to Infection control recommendations for patients with cystic fibrosis: microbiology, important pathogens, and infection control practices to prevent patient-to-patient transmission (Q51669881):
Displaying 50 items.
- Deciphering the role of RND efflux transporters in Burkholderia cenocepacia (Q28477821) (← links)
- The use of nanoscale visible light-responsive photocatalyst TiO2-Pt for the elimination of soil-borne pathogens (Q28481158) (← links)
- 2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings (Q29619731) (← links)
- Hospital epidemiology and infection control in acute-care settings (Q30429049) (← links)
- Onset of persistent pseudomonas aeruginosa infection in children with cystic fibrosis with interval censored data (Q31131422) (← links)
- Assessment of three Resistance-Nodulation-Cell Division drug efflux transporters of Burkholderia cenocepacia in intrinsic antibiotic resistance (Q33504396) (← links)
- Molecular epidemiology of methicillin-resistant Staphylococcus aureus isolated in serial cultures from the respiratory tract of children with cystic fibrosis (Q33863673) (← links)
- Seasonality of acquisition of respiratory bacterial pathogens in young children with cystic fibrosis (Q33785116) (← links)
- Antibiotic management of lung infections in cystic fibrosis. II. Nontuberculous mycobacteria, anaerobic bacteria, and fungi (Q33792765) (← links)
- The changing microbial epidemiology in cystic fibrosis (Q33825634) (← links)
- Effect that an educational program for cystic fibrosis patients and caregivers has on the contamination of home nebulizers (Q33852394) (← links)
- Viability of Pseudomonas aeruginosa in cough aerosols generated by persons with cystic fibrosis. (Q33956730) (← links)
- National athletic trainers' association position statement: skin diseases (Q33984713) (← links)
- Inhaled hypertonic saline in infants and children younger than 6 years with cystic fibrosis: the ISIS randomized controlled trial (Q34275485) (← links)
- Compliance of clinical microbiology laboratories in the United States with current recommendations for processing respiratory tract specimens from patients with cystic fibrosis (Q34568983) (← links)
- Infection control in paediatrics (Q34729760) (← links)
- Increased congregational support for parents of children with cystic fibrosis (Q35071790) (← links)
- Pseudomonas aeruginosa in cystic fibrosis patients with G551D-CFTR treated with ivacaftor (Q35127240) (← links)
- Infection control in cystic fibrosis (Q35545544) (← links)
- Clinical outcomes associated with Staphylococcus aureus and Pseudomonas aeruginosa airway infections in adult cystic fibrosis patients (Q35669548) (← links)
- The genetics of nontuberculous mycobacterial infection (Q35677183) (← links)
- Within-host microevolution of Pseudomonas aeruginosa in Italian cystic fibrosis patients (Q35813781) (← links)
- Isolation of infectious cystic fibrosis patients: results of a systematic review (Q36112367) (← links)
- Airway Microbiota in Bronchoalveolar Lavage Fluid from Clinically Well Infants with Cystic Fibrosis. (Q36216240) (← links)
- Practical management of cystic fibrosis (Q36568679) (← links)
- Molecular epidemiological surveillance of multidrug-resistant Pseudomonas aeruginosa isolates in a pediatric population of patients with cystic fibrosis and determination of risk factors for infection with the Houston-1 strain (Q36884485) (← links)
- Control of antibiotic-resistant bacteria in the office and clinic (Q37477929) (← links)
- Cystic Fibrosis Foundation evidence-based guidelines for management of infants with cystic fibrosis. (Q37633119) (← links)
- The impact of methicillin-resistant Staphylococcus aureus colonisation on paediatric cystic fibrosis patients' morbidity. (Q37779250) (← links)
- Targeting airway inflammation in cystic fibrosis in children: past, present, and future (Q37866284) (← links)
- Tobramycin Inhalation Powder™: a novel drug delivery system for treating chronic Pseudomonas aeruginosa infection in cystic fibrosis (Q37940005) (← links)
- Molecular approaches to pathogenesis study of Burkholderia cenocepacia, an important cystic fibrosis opportunistic bacterium (Q37945517) (← links)
- Staphylococcus aureus in early cystic fibrosis lung disease (Q38130897) (← links)
- European Cystic Fibrosis Society Standards of Care: Framework for the Cystic Fibrosis Centre (Q38214214) (← links)
- Evidence for the efficacy of aztreonam for inhalation solution in the management of Pseudomonas aeruginosa in patients with cystic fibrosis (Q38282581) (← links)
- Factors to consider when selecting a nebulizer for a new inhaled drug product development program. (Q38373085) (← links)
- How can the cystic fibrosis respiratory microbiome influence our clinical decision-making? (Q38635041) (← links)
- Understanding persistent bacterial lung infections: clinical implications informed by the biology of the microbiota and biofilms (Q39167799) (← links)
- Viruses in cystic fibrosis patients' airways (Q39199043) (← links)
- Comparison of the BBL CHROMagar Staph aureus agar medium to conventional media for detection of Staphylococcus aureus in respiratory samples (Q39486100) (← links)
- Ability of device to collect bacteria from cough aerosols generated by adults with cystic fibrosis (Q40485160) (← links)
- Discovery of new diketopiperazines inhibiting Burkholderia cenocepacia quorum sensing in vitro and in vivo (Q40556314) (← links)
- Burkholderia cepacia complex in Serbian patients with cystic fibrosis: prevalence and molecular epidemiology. (Q40675257) (← links)
- The social network of cystic fibrosis centre care and shared Pseudomonas aeruginosa strain infection: a cross-sectional analysis (Q40698729) (← links)
- Changing Epidemiology of the Respiratory Bacteriology of Patients With Cystic Fibrosis (Q40704655) (← links)
- Efflux-mediated resistance to a benzothiadiazol derivative effective against Burkholderia cenocepacia (Q41036943) (← links)
- Validation of AKACID plus as a room disinfectant in the hospital setting (Q41478993) (← links)
- Detection of Rapidly Growing Mycobacteria in Routine Cultures of Samples from Patients with Cystic Fibrosis (Q41866799) (← links)
- Infection prevention and control guideline for cystic fibrosis: 2013 update (Q42206103) (← links)
- Halting the spread of epidemic pseudomonas aeruginosa in an adult cystic fibrosis centre: a prospective cohort study. (Q42274835) (← links)